DBV Technologies (DBVT) Selling, General & Administrative (2020 - 2026)
DBV Technologies (DBVT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
DBV Technologies |
6.63 Bn |
6.41 Bn |
-3.90 Mn |
10.50 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
10.50 Mn |
| Dec 31, 2025 |
11.44 Mn |
| Sep 30, 2025 |
7.26 Mn |
| Jun 30, 2025 |
8.46 Mn |
| Mar 31, 2025 |
5.60 Mn |
| Dec 31, 2024 |
5.07 Mn |
| Sep 30, 2024 |
7.22 Mn |
| Jun 30, 2024 |
8.64 Mn |
| Mar 31, 2024 |
7.80 Mn |
| Dec 31, 2023 |
7.20 Mn |
| Sep 30, 2023 |
6.18 Mn |
| Jun 30, 2023 |
9.23 Mn |
| Mar 31, 2023 |
6.89 Mn |
| Dec 31, 2022 |
7.15 Mn |
| Sep 30, 2022 |
4.84 Mn |
| Jun 30, 2022 |
5.70 Mn |
| Mar 31, 2022 |
6.63 Mn |
| Dec 31, 2021 |
4.27 Mn |
| Sep 30, 2021 |
8.30 Mn |
| Jun 30, 2021 |
8.27 Mn |
